1. Home
  2. GCBC vs NYXH Comparison

GCBC vs NYXH Comparison

Compare GCBC & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCBC
  • NYXH
  • Stock Information
  • Founded
  • GCBC 1889
  • NYXH 2009
  • Country
  • GCBC United States
  • NYXH Belgium
  • Employees
  • GCBC N/A
  • NYXH N/A
  • Industry
  • GCBC Banks
  • NYXH Medical/Dental Instruments
  • Sector
  • GCBC Finance
  • NYXH Health Care
  • Exchange
  • GCBC Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • GCBC 364.4M
  • NYXH 222.3M
  • IPO Year
  • GCBC 1998
  • NYXH 2021
  • Fundamental
  • Price
  • GCBC $22.70
  • NYXH $6.20
  • Analyst Decision
  • GCBC
  • NYXH Strong Buy
  • Analyst Count
  • GCBC 0
  • NYXH 4
  • Target Price
  • GCBC N/A
  • NYXH $14.50
  • AVG Volume (30 Days)
  • GCBC 25.6K
  • NYXH 140.5K
  • Earning Date
  • GCBC 04-22-2025
  • NYXH 05-16-2025
  • Dividend Yield
  • GCBC 1.60%
  • NYXH N/A
  • EPS Growth
  • GCBC 16.16
  • NYXH N/A
  • EPS
  • GCBC 1.67
  • NYXH N/A
  • Revenue
  • GCBC $69,414,000.00
  • NYXH $4,680,609.00
  • Revenue This Year
  • GCBC N/A
  • NYXH $342.98
  • Revenue Next Year
  • GCBC N/A
  • NYXH $195.80
  • P/E Ratio
  • GCBC $13.15
  • NYXH N/A
  • Revenue Growth
  • GCBC 7.46
  • NYXH 3.98
  • 52 Week Low
  • GCBC $20.00
  • NYXH $5.55
  • 52 Week High
  • GCBC $37.25
  • NYXH $12.21
  • Technical
  • Relative Strength Index (RSI)
  • GCBC 53.24
  • NYXH 40.61
  • Support Level
  • GCBC $21.91
  • NYXH $5.81
  • Resistance Level
  • GCBC $22.91
  • NYXH $6.66
  • Average True Range (ATR)
  • GCBC 0.90
  • NYXH 0.30
  • MACD
  • GCBC 0.21
  • NYXH 0.18
  • Stochastic Oscillator
  • GCBC 85.95
  • NYXH 49.45

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: